Results for
""Apolipoprotein B-100""[mesh_terms]

Targeting structural flexibility in low density lipoprotein by integrating cryo-electron microscopy and high-speed atomic force microscopy.

Armel Bezault, Daouda A K Traore, Eaazhisai Kandiah, Sarah Stainer, Ambroise Desfosses, Aline Cisse, Anna-Laurence Schachner-Nedherer, Karin Kornmueller, Judith Peters, Ruth Prassl, Irina Gutsche, Peter Hinterdorfer, Gerd Hoerl, Gerd Leitinger

International journal of biological macromolecules 2023;252():126345

Non-high-density lipoprotein (non-HDL) cholesterol in adolescence as a predictor of atherosclerotic cardiovascular diseases in adulthood.

Siamak Khavandi, Elsa Tabibzadeh, Soheila Khavandi, Saeed Shoar, Waleed Ikram, Ahmed Ali Shah, Najam Farooq, Srikanth Gouni

Reviews in cardiovascular medicine 2021;22(2):295-299

Familial defective apolipoprotein B-100: A review.

Rolf L Andersen, Zahid Ahmad, André R Miserez, Lars H Andersen

Journal of clinical lipidology 2017;10(6):1297-1302

Diagnosis of remnant hyperlipidaemia.

Alexis Baass, Sophie Bernard, Martine Paquette

Current opinion in lipidology 2022;33(4):227-230

Relationship between "LDL-C", estimated true LDL-C, apolipoprotein B-100, and PCSK9 levels following lipoprotein(a) lowering with an antisense oligonucleotide.

Nicholas J Viney, Calvin Yeang, Xiaohong Yang, Shuting Xia, Joseph L Witztum, Sotirios Tsimikas

Journal of clinical lipidology 2019;12(3):702-710

Applying apoB to the diagnosis and therapy of the atherogenic dyslipoproteinemias: a clinical diagnostic algorithm.

Allan D Sniderman

Current opinion in lipidology 2004;15(4):433-8

Lipoprotein metabolism in obesity and diabetes: insights from stable isotope kinetic studies in humans.

Julian B Marsh

Nutrition reviews 2004;61(11):363-75

Utility of Genetically Predicted Lp(a) (Lipoprotein [a]) and ApoB Levels for Cardiovascular Risk Assessment.

J Brent Richards, Claudia Langenberg, Nicholas J Wareham, Vincent Mooser, George Thanassoulis, James C Engert, Vincenzo Forgetta, Jian'an Luan, Haoyu Wu

Circulation. Genomic and precision medicine 2022;14(5):e003312

Lomitapide and Mipomersen-Inhibiting Microsomal Triglyceride Transfer Protein (MTP) and apoB100 Synthesis.

Dirk J Blom, Frederick J Raal, Raul D Santos, A David Marais

Current atherosclerosis reports 2020;21(12):48

Non-HDL-cholesterol and apolipoprotein B compared with LDL-cholesterol in atherosclerotic cardiovascular disease risk assessment.

Stuart S Carr, Amanda J Hooper, David R Sullivan, John R Burnett

Pathology 2019;51(2):148-154

Could ornithine supplementation be beneficial to prevent the formation of pro-atherogenic carbamylated low-density lipoprotein (c-LDL) particles?

Bahadir Simsek, Ufuk Çakatay

Medical hypotheses 2019;126():20-22

A New Structural Model of Apolipoprotein B100 Based on Computational Modeling and Cross Linking.

Denis O Sviridov, Alan T Remaley, Ancha Baranova, Lance Liotta, Iosif I Vaisman, Edward B Neufeld, Diego Lucero, Grzegorz Piszczek, Amanda Haymond, Angel M Aponte, Scott M Gordon, Kianoush Jeiran

International journal of molecular sciences 2022;23(19):11480

Molecular genetic background of an autosomal dominant hypercholesterolemia in the Czech Republic.

L Tichý, L Fajkusová, P Zapletalová, L Schwarzová, M Vrablík, T Freiberger

Physiological research 2017;66(Suppl 1):S47-S54

Is it LDL particle size or number that correlates with risk for cardiovascular disease?

Radhika R Gadesam, H Robert Superko

Current atherosclerosis reports 2008;10(5):377-85